Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: An altered response in accumulation-defective resistant cells

Clinical Cancer Research

Volumn 2, Issue 6, 1996, Pages 991-999

  Marverti, Gaetano ^a,b   Andrews, Paul A ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GENISTEIN; ISOFLAVONE; MANNITOL; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSPORT KINETICS;

ANTINEOPLASTIC AGENTS; CELL MEMBRANE PERMEABILITY; CISPLATIN; ENZYME INHIBITORS; GENISTEIN; HUMANS; MANNITOL; PHOSPHORYLATION; PINOCYTOSIS; PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0029934208     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Andrews, P. A., and Howell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells (Cold Spring Harbor), 2: 35-43, 1990.
2. Andrews, P. A. Mechanisms of acquired resistance to cisplatin. In: L. J. Goldstein and R. F. Ozols (eds.), Anticancer Drug Resistance: Advances in Molecular and Clinical Research, pp. 217-246. Boston: Kluwer Academic, 1994.
3. Andrews, P. A., Jones, J. A., Varki, N. M., and Howell, S. B. Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun., 2: 93-100, 1990.
4. Teicher, B. A., Herman, T. S., Holden, S. A., Wang, Y. Y., Pfeffer, M. R., Crawford, J. W., and Frei, E., III. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science (Washington DC), 247: 1457-1461, 1990.
5. Mistry, P., Kelland, L. R., Loh, S. Y., Abel, G., Murrer, B. A., and Harrap, K. R. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines. Cancer Res., 52: 6188-6193, 1992.
6. Fichtinger-Schepman, A. M. J., Vendrik, C. P. J., van Dijk-Knijnenburg, W. C. M., de Jong, W. H., van der Minnen, A. C E., Claessen, A. M. E., van der Velde-Visser, S. D., de Groot, G., Wubs, K. L., Steerenberg, P. A., Schornagel, J. H., and Berends, F. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma. Cancer Res., 49: 2862-2867, 1989.
7. +-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells. Cancer Res., 51: 3677-3681, 1991.
8. Jekunen, A. P., Shalinsky, D. R., Hom, D. K., Albright, K. D., Heath, D., and Howell, S. B. Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem. Pharmacol., 45: 2079-2085, 1993.
9. Kikkawa, F., Kojima, M., Oguchi, H., Maeda, O., Ishikawa, H., Tamakoshi, K., Mizuno, K., Kawai, M., Suganuma, N., and Tomoda, Y. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum(II)-sensitive and -resistant ovarian carcinoma cells. Anticancer Res., 13: 891-896, 1993.
10. Morikage, T., Ohmori, T., Nishio, K., Fujiwara, Y., Takeda, Y., and Saijo, N. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Cancer Res., 53: 3302-3307, 1993.
11. Christen, R. D., Jekunen, A. P., Jones, J. A., Thiebaut, F., Shalinsky, D. R., and Howell, S. B. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. J. Clin. Invest., 92: 431-440, 1993.
12. Mann, S. C., Andrews, P. A., and Howell, S. B. Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int. J. Cancer, 48: 866-872, 1991.
13. Basu, A., Teicher, B. A., and Lazo, J. S. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J. Biol. Chem., 265: 8451-8457, 1990.
14. Kikuchi, Y., Iwano, I., Miyauchi, M., Sasa, H , Nagata, I., and Kuki, E. Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant ovarian cancer cells. Gynecol. Oncol., 39: 199-203, 1990.
15. Kawai, K., Kamatani, N., Georges, E., and Ling, V. Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum(II). J. Biol. Chem., 265: 13137-13142, 1990.
16. Bernal, S. D., Speak, J. A., Boeheim, K., Dreyfuss, A. I., Wright, J. E., Teicher, B. A., Rosowsky, A., Tsao, S. W., and Wong, Y. C. Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum. Mol. Cell. Biochem., 95: 61-70, 1990.
17. Katabami, M., Fujita, H., Honke, K., Makita, A., Akita, H., Miyamoto, H., Kawakami, Y., and Kuzumaki, N. Marked reduction of type I keratin (K14) in cisplatin-resistant human lung squamous-carcinoma cell lines. Biochem. Pharmacol., 45: 1703-1710, 1993.
18. Kelly, G. E., Nelson, C., Waring, M. A., Joannou, G. E., and Reeder, A. Y. Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta, 223: 9-22, 1993.
19. Wang, H., and Murphy, P. A. Isoflavone content in commercial soybean foods. J. Agric. Food Chem., 42: 1666-1673, 1994.
20. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262: 5592-5595, 1987.
21. Carter, R. H., Park, D., Rhee, S., and Fearon, D. T. Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes. Proc. Natl. Acad. Sci. USA, 88: 2745-2749, 1991.
22. Markovits, J., Linassier, C., Fossé, P., Couprie, J., Pierre, J., Jacquemin-Sablon, A., Saucier, J., Le Pecq, J., and Larsen, A. K. Inhibitory effects of the tyrosine inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 49: 5111-5117, 1989.
23. Andrews, P. A., Velury, S., Mann, S. C., and Howell, S. B. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48: 68-73, 1988.
24. Andrews, P. A., and Albright, K D. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res., 52: 1895-1901, 1992.
25. Zinkewich-Péotti, K., and Andrews, P. A. Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance. Cancer Res., 52: 1902-1906, 1992.
26. Chou, T. C., and Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. In: G. Weber (ed.), Advances in Enzyme Regulation, pp. 27-55. New York: Pergamon Press, 1984.
27. Moreadith, R. W., and Fiskum, G. Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal. Biochem., 137: 360-367, 1984.
28. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
29. Madara, J. L., Barenberg, D., and Carlson, S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell Biol., 102: 2125-2136, 1986.
30. Dawson, D. C. Na and Cl transport across the isolated turtle colon: parallel pathways for transmural ion movement. J. Membr. Biol., 37: 213-233, 1977.
31. Swanson, J. A., Yirinec, B. D., and Silverstein, S. C. Phorbol esters and horseradish peroxidase stimulate pinocytosis and redirect the flow of pinocytosed fluid in macrophages. J. Cell Biol., 100: 851-859, 1985.
32. Lee, R. L., Slate, D. L., Moretti, R., Alvi, K. A., and Crews, P. Marine sponge polyketide inhibitors of protein tyrosine kinase. Biochem. Biophys. Res. Commun., 184: 765-772, 1992.
33. Gately, D. P., and Howell, S. B. Cellular accumulation of the anticancer agent cisplatin: a review. Br. J. Cancer, 67: 1171-1176, 1993.
34. Mann, S. C., Andrews, P. A., and Howell, S. B. Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Chemother. Pharmacol., 25: 236-240, 1990.
35. Scanlon, K. J., Safirstein, R. L., Thies, H., Gross, R. B., Waxman, S., and Guttenplan, J. B. Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Cancer Res., 43: 4211-4215, 1983.
36. Hromas, R. A., North, J A., and Burns, C. P. Decreased cisplatin uptake by resistant L1210 leukemia cells. Cancer Lett., 36: 197-201, 1987.
37. Andrews, P. A., Mann, S. C., Velury, S., and Howell, S. B. Cisplatin uptake mediated cisplatin-resistance in human ovarian carcinoma cells. In: M. Nicolini (ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, pp. 248-254. Boston: Nijhoff, 1988.
38. Kelland, L. R., Mistry, P., Abel, G., Loh, S. Y., O'Neill, C. F., Murrer, B. A., and Harrap, K. R. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Res., 52: 3857-3864, 1992.
39. Voeltzel, T., Lavaissiere, L., Chillani, P., Benard, J., Bohuon, C., and Bidart, J-M. Detection of a 45-kDa antigen overexpressed in a cisplatin-resistant human ovarian carcinoma cell line. Hybridoma, 13: 367-372, 1994.
40. Mann, S. C., Andrews, P. A., and Howell, S. B. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Anticancer Res., 8: 1211-1215, 1988.
41. Besterman, J. M., and Low, R. B. Endocytosis: a review of mechanisms and plasma membrane dynamics. Biochem. J., 210: 1-13, 1983.
42. Bar-Sagi, D., and Feramisco, J. R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (Washington DC), 233: 1061-1068, 1986.
43. Raths, S., Rohrer, J., Crausaz, F., and Riezman, H. end3 and end4: two mutants defective in receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae. J. Cell Biol., 120: 55-65, 1993.
44. Pagliacci, M. C., Spinozzi, F., Migliorati, G., Fumi, G., Smacchia, M., Grignani, F., Riccardi, C., and Nicoletti, I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur. J. Cancer, 29A: 1573-1577, 1993.
45. Barnes, S., and Peterson, T. G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med., 208: 103-108, 1995.
46. Peterson, T. G., and Barnes, S. Isoflavones inhibit the growth of human prostate cell lines without inhibiting epidermal growth factor receptor autophosphorylation. Prostate, 22: 335-345, 1993.
47. Christen, R. D., Hom, D. K., Porter, D. C., Andrews, P. A., MacLeod, C. L., Hafstrom, L., and Howell, S. B. Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. J. Clin. Invest., 86: 1632-1640, 1990.
48. Pietras, R. J., Fendly, B. M., Chazin, V. R., Pegram, M. D., Howell, S. B., and Slamon, D. J. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene, 9: 1829-1838, 1994.
49. Isonishi, S., Andrews, P. A., and Howell, S. B. increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. J. Biol. Chem., 265: 3623-3627, 1990.
50. Hofmann, J., Doppler, W., Jakob, A., Maly, K., Posch, L., Uberall, F., and Grunicke, H H. Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int. J. Cancer, 42: 382-388, 1988.
51. Wei, H., Bowen, R., Cai, Q., Barnes, S., and Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208: 124-130, 1995.
52. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G , Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis Proc. Natl. Acad. Sci. USA, 90: 2690-2694, 1993.
53. Xu, X., Wang, H-J., Murphy, P. A., Cook, L., and Hendrich, S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr., 124: 825-832, 1994.